Holen Sie sich die Stockscreener-App
1.51
2.03%
0.03
Vorhandelsmarkt:
1.44
-0.07
-4.64%
Alector Inc Aktie (ALEC) Neueste Nachrichten
Alector Inc (ALEC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alector Inc (ALEC) Institutional Confidence - TradingKey
Alector Inc (ALEC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alector Inc (ALEC) Balance Sheet - TradingKey
TradingKey - TradingKey
Alector Inc (ALEC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ALEC|Alector Inc|Price:1.480|Chg%:-0.010 - TradingKey
Alector Inc (ALEC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ALEC|Alector Inc|Price:1.520|Chg%:+0.040 - TradingKey
Spruce Street Capital LP Buys 983,082 Shares of Alector, Inc. $ALEC - MarketBeat
Alector, Inc. Revenue Breakdown – NASDAQ:ALEC - TradingView
Alector Inc (ALEC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alector (ALEC) Goldman Sachs 45th Annual Global Healthcare Conference Summary - Quartr
Alector (ALEC) Proxy filing Summary - Quartr
Alector Q1 2026 Earnings: Narrower Loss Surprises, Yet Shares Dip Amid Revenue AbsenceCapex Guidance - DonanımHaber
GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership - Sahm
GSK exits Alector neurodegeneration alliance after trial failures - The Pharma Letter
Form 4 Alector Inc For: 9 July By Investing.com - Investing.com Nigeria
Alector (ALEC) awards 20,000 RSUs to principal accounting officer - Stock Titan
GSK ends brain drug alliance with Alector - BioPharma Dive
GSK Bids Farewell To Alector Dementia Deal - insights.citeline.com
GSK Walks Away From AlectorPipeline Reset Story Begins (NASDAQ:ALEC) - Seeking Alpha
GSK Terminates Neuroscience Collaboration with Alector Following Drug Trial SetbacksEPS Surprise History - dars.gov.et
Alector stock plummets 13% as GSK terminates neuroscience pact (GSK:NYSE) - Seeking Alpha
Alector (ALEC) Shares Drop 13% Following Termination of GSK Coll - GuruFocus
Alector and GSK partnership to end after dementia, Alzheimer’s drug failures - whbl.com
Alector, Inc. Terminates Material Definitive Agreement – Key 8-K Filing Update July 2026 - Minichart
Alector and GSK partnership to end after dementia, Alzheimer's drug failures - Reuters
Alector Ends GSK Collaboration, Retires Hercules Capital Debt - TipRanks
Alector to End GSK Progranulin Collaboration; Repays $10.4 Million Hercules Loan - TradingView
Alector (ALEC) sees GSK end antibody collaboration while repaying $10.4M loan - Stock Titan
ALEC Q1 2026 Earnings: Narrowing Losses with 39.95% EPS Beat; Stock Rises 2.49%Investor Earnings Call - dars.gov.et
Alector Inc. (ALEC) Recovers From Support as Shares Edge HigherValue Area Low - DonanımHaber
ALEC Q1 2026 Earnings: Smaller-than-Expected Loss Drives Positive SentimentEarnings Surprise Stocks - dars.gov.et
0Z2 Forecast — Price Target — Prediction for 2027 - TradingView
Alector, Inc. Actuals & Estimates (NASDAQ:ALEC) - TradingView
ALEC Forecast — Price Target — Prediction for 2027 - TradingView
Alector (ALEC) Surges 11.45% as Shares Test Key Resistance at $2.1Buy Signal Reports - dars.gov.et
A2PCBM Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Price to sales forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Enterprise value to revenue forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Price to sales forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Price to book forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Enterprise value to EBITDA forward of Alector, Inc. – GETTEX:0Z2 - TradingView
Enterprise value to EBIT forward of Alector, Inc. – NASDAQ:ALEC - TradingView
Alector Inc. (ALEC) Q1 2026 Earnings: EPS Beat on Narrower Loss, No Revenue YetEarnings Season Outlook - dars.gov.et
Alector Inc. (ALEC) Edges Higher as Stock Approaches Key ResistanceCall Wall - dars.gov.et
ALEC Q1 2026 Earnings: Better-than-Expected Loss Narrowing Drives Double-Digit Stock SurgeEstimate Accuracy - dars.gov.et
ALEC Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Double-Digit RallyGeographic Revenue Trends - dars.gov.et
Alector (ALEC) Stock Faces Mixed Analyst Target Changes On Tau Therapy Readthrough - Yahoo Finance
Alector Inc (ALEC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Alector Inc (ALEC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alector Inc (ALEC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):